MX9605728A - Formulation preparation device. - Google Patents

Formulation preparation device.

Info

Publication number
MX9605728A
MX9605728A MX9605728A MX9605728A MX9605728A MX 9605728 A MX9605728 A MX 9605728A MX 9605728 A MX9605728 A MX 9605728A MX 9605728 A MX9605728 A MX 9605728A MX 9605728 A MX9605728 A MX 9605728A
Authority
MX
Mexico
Prior art keywords
fluids
formulation preparation
spikes
combined
port
Prior art date
Application number
MX9605728A
Other languages
Spanish (es)
Inventor
Joel Portnoff
Royden M Coe
John Grimm
Kenneth Raines
Joel Bartholomew
Original Assignee
Liposome Co Inc
Braun Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc, Braun Medical Inc filed Critical Liposome Co Inc
Priority claimed from PCT/US1995/006480 external-priority patent/WO1995031955A2/en
Publication of MX9605728A publication Critical patent/MX9605728A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A formulation preparation device is provided herein which contains a valve assembly, transfer spikes, syringe port and tube, these components being interconnected so as to provide for controlled fluid flow between the spikes and port, through the assembly, in specific directions only. The device has an enclosed, sterilizable, grippable housing and can be used to mix combine fluids in reproducible and predetermined proportions. Combination is accomplished aseptically, avoiding contact between the device's operator and the fluids and the substances combined. Biologically active compounds can be combined with one or more fluids, including such aqueous liposome suspensions, using the device. A formulation preparation kit containing, in addition to the device, the fluids and compounds to be formulated is thus also provided herein; methods of using the device to prepare such formulations are further provided herein.
MX9605728A 1995-05-23 1995-05-23 Formulation preparation device. MX9605728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/006480 WO1995031955A2 (en) 1994-05-23 1995-05-23 Formulation preparation device

Publications (1)

Publication Number Publication Date
MX9605728A true MX9605728A (en) 1998-02-28

Family

ID=39165171

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605728A MX9605728A (en) 1995-05-23 1995-05-23 Formulation preparation device.

Country Status (1)

Country Link
MX (1) MX9605728A (en)

Similar Documents

Publication Publication Date Title
IL113832A (en) Formulation preparation device
CA2380657A1 (en) Disposable test vial with sample delivery device
EP0196038A3 (en) Azolyl methyl oxiranes, their preparation and use as plant-protecting agents
DE69807072D1 (en) FLOW CONTROLLER CONFIGURATIONS FOR A DEVICE DELIVERING ACTIVE SUBSTANCE
CA2024291A1 (en) Dosage device and preparation and use thereof
ES2183842T3 (en) NEEDLE VALVE FOR USE IN INTRAVENOUS INFUSIONS.
CA2058964A1 (en) Two-way valve for infusion devices
MX9102814A (en) ADMINISTRATION FORM FOR ECO-CONTRASTING AGENTS IN MICROBUBBLES.
RU94045914A (en) Device for infusion
TWI255737B (en) A straw for the conservation of small quantities of substances, in particular biological liquids
MX9605728A (en) Formulation preparation device.
MXPA05009672A (en) Method and disposable device for sampling and distributing a liquid, for example, in sterile conditions.
EP0391852A3 (en) Pharmaceutical compositions
ES2000033A6 (en) Liquid stable anthelmintic and fungicidal composition based on bithionol sulfoxide.
AU8211287A (en) Ectoparasiticidal non-aqueous liquid pour-on formulations
SE9501909L (en) Sampling device for sampling a certain amount of organic body fluid
ES2139769T3 (en) USE OF AZOLS AS VIRICIDAL AGENTS IN BIOLOGICALLY ACTIVE PROTEIN SOLUTIONS.
WO2000062910A3 (en) A venturi feed device and fluid mixing device
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AR014969A1 (en) FORMULATION CONTAINING AT LEAST ONE LATE PROTEIN (PROTEIN L) OF ONE OR MORE PAPILOMAVIRUS AND / OR AT LEAST ONE EARLY PROTEIN (PROTEIN E) ONE OR MORE PAPILOMAVIRUS, PROCEDURE FOR THE PREPARATION OF THE FORMULATION MENTIONED AS WELL AS ITS USE MANUFACTURE OF A MEDICINAL PRODUCT
ATE251137T1 (en) INDOLE DERIVATIVES AND ROOT-FORMING AGENTS CONTAINING THESE AS ACTIVE INGREDIENTS
ES2156181T3 (en) USE OF A DISKLACE AS A STABILIZER OF LIQUID PROTEIN MIXTURES AND LIQUID PROTEIN MIXTURES CONTAINING A DISKLAR.
ATE111731T1 (en) PHARMACEUTICAL PREPARATION FOR RECTAL ADMINISTRATION.
ATE187319T1 (en) THERAPEUTIC COLD-HOT COMPRESS
Munteanu et al. Transient flow of blood in arteries.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: AVENTIS INC.

Owner name: CEPHALON LIMITED

PD Change of proprietorship

Owner name: CEPHALON LIMITED

MM Annulment or lapse due to non-payment of fees